4/17
01:44 pm
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
4/17
01:44 pm
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
4/17
01:44 pm
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
3/20
08:05 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $52.00 price target on the stock.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $52.00 price target on the stock.
3/20
07:10 am
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
3/14
08:36 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $52.00 price target on the stock.
Medium
Report
REGENXBIO Inc. (NASDAQ: RGNX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $52.00 price target on the stock.
3/14
08:30 am
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
3/14
08:16 am
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
3/14
08:16 am
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
2/11
04:57 am
rgnx
Rating for RGNX
Medium
Report
Rating for RGNX
2/11
04:57 am
rgnx
Rating for RGNX
Medium
Report
Rating for RGNX
2/11
04:57 am
rgnx
Rating for RGNX
Medium
Report
Rating for RGNX
2/11
04:34 am
rgnx
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
2/11
04:34 am
rgnx
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
2/11
04:34 am
rgnx
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
Medium
Report
Regenxbio downgraded to Neutral from Buy at Goldman Sachs
2/8
06:51 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Medium
Report
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at Raymond James to a "moderate buy" rating.
2/8
06:51 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Medium
Report
REGENXBIO Inc. (NASDAQ: RGNX) was upgraded by analysts at Raymond James to a "moderate buy" rating.
2/7
11:07 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock.
2/7
11:07 am
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $27.00 price target on the stock.
1/21
12:19 pm
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $30.00 price target on the stock.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $30.00 price target on the stock.
1/21
12:19 pm
rgnx
REGENXBIO Inc. (NASDAQ: RGNX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $30.00 price target on the stock.
Low
Report
REGENXBIO Inc. (NASDAQ: RGNX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $30.00 price target on the stock.
1/21
12:15 pm
rgnx
Rating for RGNX
Low
Report
Rating for RGNX
1/21
12:15 pm
rgnx
Rating for RGNX
Low
Report
Rating for RGNX